NIH-funded research R21 grant

Creating a tool to identify men at high risk for HIV in sub-Saharan Africa

Official title: Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa

Funded at Univ of North Carolina Chapel Hill · NIH-10762645 · Data updated 2026-11-12

This study is creating a helpful tool to find men in sub-Saharan Africa who are most at risk of getting HIV, so they can get the right prevention support, like PrEP, to stay healthy.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 1, 2023
Project endJuly 31, 2025
Funding year2023
Award (this year)$416,750
NIH project number1R21MH134750-01
Project IDNIH-10762645 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adult men living in sub-Saharan Africa who are at risk of HIV acquisition.

Less likely to help

Patients who are not men or those who are not at risk of HIV acquisition may not benefit from this research.

What this research studies

This research aims to develop a risk assessment tool specifically designed to identify men in sub-Saharan Africa who are at the highest risk of acquiring HIV. By analyzing data from multiple national surveys, the project will utilize rigorous analytic methods to create a tool that can effectively stratify risk among men, ensuring that those most in need of preventive measures like PrEP receive them. The approach focuses on addressing the limitations of existing tools that have primarily been developed for women. Ultimately, this tool will help target HIV prevention efforts more effectively.

Why it matters

Potential benefit: If successful, this research could significantly improve HIV prevention strategies by ensuring that high-risk men receive timely and appropriate interventions.

How similar studies have gone: Previous research has shown success in developing risk assessment tools for women, but this approach for men is relatively novel.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Rosenberg, Nora — Univ of North Carolina Chapel Hill
  • Study coordinator: Rosenberg, Nora

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.